Archive for ◊ February, 2014 ◊

• Thursday, February 20th, 2014

Kalamazoo, Michigan – February 18, 2014 – Stryker Corporation (NYSE:SYK) announced today a definitive agreement to acquire Berchtold Holding, AG (Berchtold) for an enterprise value of $172 million. Berchtold, a privately held business with operating facilities in Germany and the United States, sells world-class surgical infrastructure equipment. Berchtold has been providing customer-centric healthcare equipment for […]

• Thursday, February 20th, 2014

Smiths Medical president Srini Seshadri steps down, making way for Zimmer executive Jeff McCaulley. Smiths Medical president Srini Seshadri is expected to step down, and Zimmer (NYSE:ZMH) executive Jeff McCaulley will step into the top office. There was no reason given for Seshadri’s departure. He joined the company in 2006 and helped navigate some tough […]

• Thursday, February 20th, 2014

Nuclea Biotechnologies Inc. has received more than $510,000, in tax incentives from the Massachusetts Life Sciences Center — on the condition it creates 25 full-time jobs in 2014. Patrick J. Muraca, president and CEO of the firm, said the majority of those new positions — between 17 and 20 — will be created in Pittsfield. […]

• Thursday, February 20th, 2014

Arthrex loses its bid for a new trial in its patent infringement war with KFx Medical, but must pay royalties on sales of its SpeedBridge and SutureBridge shoulder anchor devices.   A $29 million judgment against Arthrex will stand in its patent war with KFx Medical after a federal judge in California declined to grant […]

• Friday, February 14th, 2014

Medtronic Launches ‘TOTAL Across’ Crossing Catheter in Europe  MINNEAPOLIS — Feb. 13, 2014 — Aligned with its commitment to provide innovative medical technology for the interventional treatment of peripheral artery disease, Medtronic, Inc. (NYSE: MDT) has initiated the European launch of the TOTAL across crossing catheter, which recently received the CE (Conformité Européene) mark as […]

• Friday, February 14th, 2014

A deal by Medtronic Inc. to jettison an anti-snoring product to a Dallas clinic will return the manufacturing of the technology to Minnesota, where it was developed by the former Restore Medical. Fridley-based Medtronic quietly sold off its Pillar Palatal procedure — a minimally invasive treatment that uses polyester implants embedded in a patient’s palate to stop […]

• Thursday, February 13th, 2014

The Vanguard Group buys a big stake in Boston Scientific as BlackRock expands its holdings in the medical device company. Count mutual fund giant Vanguard Group and hedge fund BlackRock Inc. among the believers in the comeback story at Boston Scientific (NYSE:BSX). Vanguard took up a 6.7% stake in Boston Scientific as of the end of last […]

• Wednesday, February 05th, 2014

Like little factories, cells metabolize raw materials and convert them into chemical compounds. Biotechnologists take advantage of this ability, using microorganisms to produce pharmaceuticals and biofuels. To boost output to an industrial scale and create new types of chemicals, biotechnologists manipulate the microorganisms’ natural metabolism, often by “overexpressing” certain genes in the cell. But such […]

• Tuesday, February 04th, 2014

A lineup of medical device entrepreneurs are working with doctors in UCSF’s Department of Surgery and bioengineering graduate students to honor a longtime colleague by shaping life-saving products from fresh ideas. The Rosenman Institute, a new organization set up under the umbrella of the University of California’s QB3 institute, launched this month with some 20 […]

• Tuesday, February 04th, 2014

Bard Announces $500 Million Share Repurchase Authorization MURRAY HILL, N.J.–(BUSINESS WIRE)–C. R. Bard, Inc. (NYSE:BCR) today announced that its Board of Directors has authorized the repurchase of up to $500 million of the company’s common stock. This new authorization is in addition to the approximately $55 million remaining under the Company’s prior authorization. Share repurchases […]